GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 29, 2014

Drug R&D: Big Data for Big Returns

More ROI from research and development is urgently needed.

Drug R&D: Big Data for Big Returns

Both access to big data and fully realizing success from its use require the right relationships within the greater healthcare/life sciences ecosystem. [© kentoh - Fotolia.com]

  • Cost pressures and new pay-for-performance payer approaches are making demonstration of real-world outcomes as essential to the drug research and development (R&D) model as ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?